ScreenerHero

RJF LABORATORIO REIG JOFRE, S.A.

BME · ES · Healthcare · Drug Manufacturers - Specialty & Generic · reigjofre.com
2.610EUR+1.56%Mkt Cap: 232.83M $P/E: 32.63

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$64.70BUSDP/E 25.1
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
ZOE
Zoetis Inc.
$27.77BUSDP/E 11.5
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.51BUSDP/E 22.6
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
HIK
Hikma Pharmaceuticals PLC
$4.19BUSDP/E 11.9

Key Statistics

Company
Market Cap232.83M USD
Enterprise Value342.67M USD
Revenue (TTM)367.10M USD
Gross Profit212.88M USD
Net Income (TTM)5.46M USD
Revenue/Share4.14 EUR
Last Price2.610 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.5K
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0165359029
Valuation
P/E (Trailing)32.63
P/E (Forward)21.33
PEG0.58
EV/EBITDA13.08
EV/Revenue0.93
P/S0.62
P/B0.96
EPS (TTM)0.08
EPS (Forward)0.12
52W Range
2.32028% of range3.350
52W High3.350 EUR
52W Low2.320 EUR
Profitability
Gross Margin59.15%
Oper. Margin1.82%
EBITDA Margin7.14%
Profit Margin1.52%
ROE2.30%
ROA1.27%
Growth
Revenue Growth1.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.65M USD
CapEx (TTM)19.90M USD
FCF Margin—
FCF Yield—
Net Debt113.55M USD
Net Debt/EBITDA4.33
Balance Sheet
Debt/Equity0.42
Current Ratio1.51
Quick Ratio0.80
Book Value/Sh2.68 EUR
Cash/Share0.19 EUR
Dividends
Fwd Div Rate0.02 EUR
Trail. Div Rate0.00 EUR
Div. Yield0.94%
5Y Avg Yield1.52%
Payout Ratio30.00%
Ex-Div DateMay 21, 2026
Pay Date—
Splits
Last Split1:20
Split DateSep 22, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.82.07M
Float21.96M
Insiders78.46%
Institutions6.28%
Technical
SMA 502.661 (-1.9%)
SMA 2002.648 (-1.4%)
Beta0.95
S&P 52W Chg13.94%
Avg Vol (30d)8.07K
Avg Vol (10d)13.44K
Technical Indicators
RSI (14)48.6
MACD-0.0286
MACD Signal-0.0274
MACD Hist.-0.0012
BB Upper2.701 EUR
BB Middle2.611 EUR
BB Lower2.520 EUR
BB Width6.95%
ATR (14)0.0573 EUR
Vol Ratio (20d)0.38x